Riskpilot← Back to searchSign inGet full accessSolomed AB
ABActiveOrg 5568884521Sofiehemsvägen 14General medical practice activities · NACE 8621Est. 20120 employees
Revenue 2026
SEK 796K
+12% vs 2025
EBITDA margin
88.7%
+10% vs 2025
Equity ratio
67.7%
Financial strength
Net profit 2026
SEK 558K
+9% vs 2025
| Revenue | SEK 796K | +12% |
| EBITDA | SEK 706K | +10% |
| Net profit | SEK 558K | +9% |
| Total assets | SEK 938K | +6% |
| Equity | SEK 635K | +10% |
| Employees | 0 | — |
Legal name
Solomed AB
Org number
5568884521
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 mars 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2026-01-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska i huvudsak bedriva uthyrning av sjukvårdstjänster. Även föreläsningar och kursverksamhet inom hälso- och sjukvård, fastighetsförvaltning..
Address
Sofiehemsvägen 14
Email
olofbackman80@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 187 | 451 | 516 | 711 | 796 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 144 | 397 | 477 | 644 | 706 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 144 | 397 | 477 | 644 | 706 |
| Net financials | — | — | 1 | 2 | — |
| Profit before tax | 144 | 397 | 478 | 647 | 706 |
| Tax | −24 | −84 | −109 | −133 | −148 |
| Net profit | 120 | 313 | 369 | 514 | 558 |
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Total assets | 298 | 562 | 779 | 888 | 938 |
| Equity | 281 | 394 | 513 | 576 | 635 |
| Long-term debt | 17 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 168 | 267 | 311 | 303 |
| Total debt | 17 | 168 | 267 | 311 | 303 |
EBITDA margin
88.7%
This company
15.8%
Market median
+461% vs market
20222026
Equity ratio
67.7%
This company
38.2%
Market median
+77% vs market
20222026
Return on equity
87.9%
This company
18.4%
Market median
+378% vs market
20222026
Net profit margin
70.1%
This company
8.1%
Market median
+765% vs market
20222026
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20222026
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20222026
- Annual report 2026Filed via Bolagsverket / SCB · Period 2025-02-01 – 2026-01-31
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-02-01 – 2022-01-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Solomed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Olof Backman | Chairman | 0 companies |
| Sofia Margareta Backman | Board of Directors | 0 companies |
| Clas Olov Backman | Deputy Board Member | 0 companies |